Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6083-6090
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6083
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6083
Table 1 Comparison of the clinical outcomes between the two study groups
Group | CR, n (%) | PR, n (%) | SD, n (%) | PD, n (%) | ORR (%) |
FLOT group (n = 42) | 0 (0.00) | 23 (54.76) | 14 (33.33) | 5 (11.90) | 54.76 |
SOX group (n = 42) | 0 (0.00) | 14 (33.33) | 15 (35.71) | 13 (30.95) | 33.33 |
- Citation: Zheng L, Gan LH, Yao L, Li B, Huang YQ, Zhang FB, Kuang MQ, Fang N. Serum basic fibroblast growth factor and interleukin-1β predict the effect of first-line chemotherapy in patients with advanced gastric cancer. World J Clin Cases 2023; 11(26): 6083-6090
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6083.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6083